These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7294975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR, Wåhlin B, Andersson T, Perlmann P.
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [Abstract] [Full Text] [Related]

  • 3. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW, Cole AJ, Hubbard RA.
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
    Neville ME.
    J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Natural killer activity of human lymphocytes against colon cancer cells.
    Helms RA, Bull DM.
    Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1980 Apr; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 12. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R, Sakurada M, Kobayashi Y, Uehara A, Matsushima K, Ueda R, Nakamura K, Shitara K.
    Clin Cancer Res; 2005 Mar 15; 11(6):2327-36. PubMed ID: 15788684
    [Abstract] [Full Text] [Related]

  • 13. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB.
    Clin Cancer Res; 2008 Jul 15; 14(14):4650-7. PubMed ID: 18628480
    [Abstract] [Full Text] [Related]

  • 14. Antibody dependent cellular cytotoxicity of lymphocytes in patients with renal diseases of immunopathological origin.
    Láng I, Kenéz B, Nagy ZK, Sonkoly I, Pálóczi K, Szegedi G, Fekete B, Gergely P.
    Clin Nephrol; 1978 Mar 15; 9(3):111-4. PubMed ID: 565267
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cation requirement of natural, in-vitro generated and antibody dependent killing exerted by human lymphocytes.
    Argov S, Poros A, Klein E.
    Immunobiology; 1979 Aug 15; 156(1-2):25-34. PubMed ID: 540969
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL, Anderson SK, Sayers TJ, Chambers WH, Palumbo GA, Young HA, Ortaldo JR.
    J Immunol; 1995 Jan 01; 154(1):80-7. PubMed ID: 7995961
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.